|
| Status |
Public on Feb 27, 2008 |
| Title |
CD34AML_UT_6 h_patient_13 |
| Sample type |
RNA |
| |
|
| Source name |
CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with UT
|
| Organism |
Homo sapiens |
| Characteristics |
CD34+ AML Patient 13 Treatment with UT 6 h
|
| Extracted molecule |
total RNA |
| Extraction protocol |
Qiagen RNeasy
|
| Label |
biotin
|
| Label protocol |
Ovation Biotin RNA Amplification and Labeling System (NuGEN)
|
| |
|
| Hybridization protocol |
Affymetrix
|
| Scan protocol |
GeneChip Scanner 3000 7G, GCOS
|
| Description |
CD34+ AML Patient 13 Treatment with UT 6 h
|
| Data processing |
MAS 5.0 (BioConductor) Scale 100
|
| |
|
| Submission date |
Apr 17, 2007 |
| Last update date |
Aug 28, 2018 |
| Contact name |
Duane Hassane |
| Organization name |
Weill Cornell Medical College
|
| Street address |
1305 York Avenue, Box 140
|
| City |
New York |
| State/province |
NY |
| ZIP/Postal code |
10021 |
| Country |
USA |
| |
|
| Platform ID |
GPL570 |
| Series (1) |
| GSE7538 |
Treatment of primary acute myelogenous leukemia (AML) specimens with parthenolide (PTL) |
|
| Relations |
| Reanalyzed by |
GSE64985 |
| Reanalyzed by |
GSE119087 |
